Taviratx
1 known investors
Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
Founders & leadership
EH
Els HenckaertsCo-founder
BM
Benjamien MoeyaertCo-founder
VB
Veronick BenoyCo-founder
VK
Vibha Kiran TamboliCo-founder
IV
Inge Van HoveCo-founder
Investors · 1
Frequently asked questions
- What does Taviratx do?
- Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
- Who founded Taviratx?
- Taviratx was founded by Els Henckaerts, Benjamien Moeyaert, Veronick Benoy, Vibha Kiran Tamboli, Inge Van Hove.
- Who are Taviratx's investors?
- Taviratx's investors include GENERAL INCEPTION.